Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2513 | 3376 | 47.8 | 93% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
100 | 72119 | HER 2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
2608 | 2122 | FOCAL ADHESION KINASE//FAK//PYK2 |
16389 | 592 | INTEGRIN LINKED KINASE//ILK//INTEGRIN LINKED KINASE ILK |
24133 | 270 | DLC1//DELETED IN LIVER CANCER 1//DLC 1 |
24562 | 258 | KINDLIN 2//KINDLIN//KINDLER SYNDROME |
30679 | 134 | SCHLAFEN//SURG SERV 11S//SCHLAFEN 3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FOCAL ADHESION KINASE | Author keyword | 187 | 41% | 11% | 357 |
2 | INTEGRIN LINKED KINASE | Author keyword | 167 | 68% | 4% | 145 |
3 | FAK | Author keyword | 141 | 39% | 9% | 290 |
4 | KINDLIN 2 | Author keyword | 81 | 96% | 1% | 25 |
5 | ILK | Author keyword | 80 | 63% | 2% | 80 |
6 | PYK2 | Author keyword | 63 | 52% | 3% | 86 |
7 | PAXILLIN | Author keyword | 49 | 32% | 4% | 130 |
8 | DLC1 | Author keyword | 48 | 77% | 1% | 33 |
9 | KINDLIN | Author keyword | 45 | 83% | 1% | 25 |
10 | DELETED IN LIVER CANCER 1 | Author keyword | 33 | 100% | 0% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FOCAL ADHESION KINASE | 187 | 41% | 11% | 357 | Search FOCAL+ADHESION+KINASE | Search FOCAL+ADHESION+KINASE |
2 | INTEGRIN LINKED KINASE | 167 | 68% | 4% | 145 | Search INTEGRIN+LINKED+KINASE | Search INTEGRIN+LINKED+KINASE |
3 | FAK | 141 | 39% | 9% | 290 | Search FAK | Search FAK |
4 | KINDLIN 2 | 81 | 96% | 1% | 25 | Search KINDLIN+2 | Search KINDLIN+2 |
5 | ILK | 80 | 63% | 2% | 80 | Search ILK | Search ILK |
6 | PYK2 | 63 | 52% | 3% | 86 | Search PYK2 | Search PYK2 |
7 | PAXILLIN | 49 | 32% | 4% | 130 | Search PAXILLIN | Search PAXILLIN |
8 | DLC1 | 48 | 77% | 1% | 33 | Search DLC1 | Search DLC1 |
9 | KINDLIN | 45 | 83% | 1% | 25 | Search KINDLIN | Search KINDLIN |
10 | DELETED IN LIVER CANCER 1 | 33 | 100% | 0% | 13 | Search DELETED+IN+LIVER+CANCER+1 | Search DELETED+IN+LIVER+CANCER+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PP125FAK | 223 | 65% | 6% | 211 |
2 | ILK | 220 | 77% | 4% | 149 |
3 | FAK | 177 | 53% | 7% | 232 |
4 | FOCAL ADHESION KINASE | 124 | 14% | 24% | 806 |
5 | PAXILLIN | 77 | 33% | 6% | 193 |
6 | FOCAL ADHESION PROTEIN | 59 | 59% | 2% | 66 |
7 | ONLY PROTEIN PINCH | 48 | 91% | 1% | 20 |
8 | PYK2 | 42 | 46% | 2% | 69 |
9 | INTEGRIN LINKED KINASE | 38 | 18% | 6% | 189 |
10 | MITOGEN INDUCIBLE GENE 2 | 37 | 100% | 0% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Focal adhesion kinase: In command and control of cell motility | 2005 | 1037 | 119 | 53% |
FAK in cancer: mechanistic findings and clinical applications | 2014 | 24 | 129 | 75% |
FAK signaling in human cancer as a target for therapeutics | 2015 | 2 | 265 | 73% |
Signal transduction by focal adhesion kinase in cancer | 2009 | 222 | 165 | 72% |
Transduction - Integrin signaling | 1999 | 2771 | 123 | 36% |
The role of focal-adhesion kinase in cancer. A ew therapeutic opportunity | 2005 | 489 | 117 | 68% |
Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis | 2011 | 90 | 88 | 75% |
ILK, PINCH and parvin: the tIPP of integrin signalling | 2006 | 348 | 127 | 63% |
The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase! | 2010 | 108 | 109 | 67% |
Understanding the Roles of FAK in Cancer: Inhibitors, Genetic Models, and New Insights | 2015 | 1 | 113 | 81% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL CELL BIOL TUMOR BIOL | 18 | 67% | 0.5% | 16 |
2 | KARL LANDSTEINER THORAC ONCOL | 6 | 71% | 0.1% | 5 |
3 | CELL ADHES SIGNALING | 6 | 100% | 0.1% | 4 |
4 | JACK BELL | 5 | 17% | 0.8% | 28 |
5 | VASC ADHES | 4 | 67% | 0.1% | 4 |
6 | TISSUE REGENERAT REPAIR | 4 | 20% | 0.6% | 19 |
7 | HARVARD MED EXPT MED | 4 | 75% | 0.1% | 3 |
8 | SURG SERV 11S | 3 | 50% | 0.1% | 5 |
9 | ABORAT PROGRAM CELL ADHES MOL | 3 | 100% | 0.1% | 3 |
10 | STOMATOL ANAT | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000034026 | ALPHAVBETA3 INTEGRIN//CILENGITIDE//DISCOIDIN DOMAIN RECEPTOR |
2 | 0.0000032855 | TETRASPANIN//CD9//CD151 |
3 | 0.0000018988 | LAMININ//FIBRONECTIN//INVASION & METASTASIS |
4 | 0.0000017508 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |
5 | 0.0000014664 | WISKOTT ALDRICH SYNDROME//GELSOLIN//COFILIN |
6 | 0.0000013003 | E SELECTIN//SELECTIN//ICAM 1 |
7 | 0.0000012648 | EPITHELIAL MESENCHYMAL TRANSITION//EMT//SNAIL |
8 | 0.0000012361 | CARDIAC TISSUE ENGINEERING//TISSUE ENGINEERING//ADV BIOMED ENGN SCI |
9 | 0.0000010587 | IQGAP1//LRIG1//MIG 6 |
10 | 0.0000010237 | PTP1B//PROTEIN TYROSINE PHOSPHATASE//PRL 3 |